4951 - 4975 of 9034 Results
Title
Year
-
RESTRICTEDTitle: Parkinson's Disease Biomarkers: Resources for Discovery and ValidationJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 39Issue #: 1Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/npp.2013.246Best OA location URL: https://www.nature.com/articles/npp2013246.pdfCitation Count: 6
-
RESTRICTEDTitle: Abstracts from the 50th European Society of Human Genetics Conference: PostersJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 26Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7Best OA location URL: https://www.nature.com/articles/s41431-018-0247-7.pdfCitation Count: 0
- Dysregulated miRNAs mark Parkinson’s disease progression2021RESTRICTEDTitle: Dysregulated miRNAs mark Parkinson’s disease progressionJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 241End Page: 242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00046-2Citation Count: 3
-
OPENTitle: Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 80Issue #: 9Start Page: 969End Page: 969Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2023.2338Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2807607/jamaneurology_erickson_2023_oi_230049_1689611082.26721.pdfCitation Count: 45
-
OPENTitle: Proposed research criteria for prodromal behavioural variant frontotemporal dementiaJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1079End Page: 1097Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab365Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1079/43500015/awab365.pdfCitation Count: 102
-
OPENTitle: Neurofilament light levels predict clinical progression and death in multiple system atrophyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 12Start Page: 4398End Page: 4408Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awac253Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awac253/46502457/awac253.pdfCitation Count: 73
-
OPENTitle: Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 7Start Page: 2541End Page: 2554Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac177Best OA location URL: https://academic.oup.com/brain/article-pdf/145/7/2541/45191149/awac177.pdfCitation Count: 101
-
OPENTitle: Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cordJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 9Start Page: 3108End Page: 3130Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awac165Best OA location URL: https://academic.oup.com/brain/article-pdf/145/9/3108/45824171/awac165.pdfCitation Count: 78
-
OPENTitle: American Football Play and Parkinson Disease Among MenJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 6Issue #: 8Start Page: e2328644End Page: e2328644Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2023.28644Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2808207/bruce_2023_oi_230825_1691002545.87841.pdfCitation Count: 27
-
OPENTitle: Heterozygous PRKN mutations are common but do not increase the risk of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 6Start Page: 2077End Page: 2091Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1093/brain/awab456Best OA location URL: https://academic.oup.com/brain/article-pdf/145/6/2077/45614432/awab456.pdfCitation Count: 67
-
OPENTitle: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2629End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac281Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2629/45599741/awac281.pdfCitation Count: 1
-
OPENTitle: Autonomic changes in Huntington’s disease correlate with altered central autonomic network connectivityJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 5Start Page: fcac253End Page: fcac253Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcac253Best OA location URL: https://academic.oup.com/braincomms/article-pdf/4/5/fcac253/46682644/fcac253.pdfCitation Count: 13
- The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity2022OPENTitle: The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicityJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1083/jcb.202010065Best OA location URL: https://escholarship.org/uc/item/4764f6j3Citation Count: 18
- Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expression2022OPENTitle: Brain atrophy in prodromal synucleinopathy is shaped by structural connectivity and gene expressionJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 9Start Page: 3162End Page: 3178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac187Best OA location URL: https://academic.oup.com/brain/article-pdf/145/9/3162/45824139/awac187.pdfCitation Count: 51
-
OPENTitle: Non-reference genome transposable elements (TEs) have a significant impact on the progression of the Parkinson’s diseaseJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 247Issue #: 18Start Page: 1680End Page: 1690Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702221117147Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9597212Citation Count: 18
-
OPENTitle: Chemosensory Dysfunction 3-Months After COVID-19, Medications and Factors Associated with Complete RecoveryJournal Name: Annals of Otology, Rhinology & LaryngologyPublisher: SAGE PublicationsVol: 132Issue #: 10Start Page: 1177End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/00034894221138485Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9742352Citation Count: 3
- Evaluation of the Dementia Apraxia Test in Parkinson’s Disease Patients2022RESTRICTEDTitle: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease PatientsJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 51Issue #: 3Start Page: 271End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000525618Citation Count: 2
- Hippocampal Functional Connectivity in Parkinson’s Disease2022RESTRICTEDTitle: Hippocampal Functional Connectivity in Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 29End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000526377Citation Count: 8
-
OPENTitle: Longitudinal intronic RNA-Seq analysis of Parkinson’s disease patients reveals disease-specific nascent transcriptionJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 247Issue #: 11Start Page: 945End Page: 957Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702221081027Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15353702221081027Citation Count: 12
-
OPENTitle: Quantification of the purinergic P2X7 receptor with [11C]SMW139 improves through correction for brain-penetrating radiometabolitesJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 43Issue #: 2Start Page: 258End Page: 268Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/0271678x221126830Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X221126830Citation Count: 11
-
OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related ResearchJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #: 1Start Page: 67End Page: 76Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
-
OPENTitle: Explainable machine learning with pairwise interactions for the classification of Parkinson’s disease and SWEDD from clinical and imaging featuresJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 16Issue #: 5Start Page: 2188End Page: 2198Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11682-022-00688-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-022-00688-9.pdfCitation Count: 34
-
OPENTitle: Opicapone as an Add-on to Levodopa in Patients with Parkinson’s Disease Without Motor Fluctuations: Rationale and Design of the Phase III, Double-Blind, Randomised, Placebo-Controlled EPSILON TrialJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 3Start Page: 1409End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-022-00371-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-022-00371-7.pdfCitation Count: 10
- Editor's Note2022RESTRICTEDTitle: Editor's NoteJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1329End Page: 1329Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29149Citation Count: 0
- Quantitative determination of LY‐404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MS2022RESTRICTEDTitle: Quantitative determination of LY‐404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MSJournal Name: Biomedical ChromatographyPublisher: WileyVol: 36Issue #: 9Start Page: e5423End Page: e5423Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/bmc.5423Citation Count: 2